© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Mosapride Citrate came onto the pharmaceutical scene in the mid-1990s, a result of Japanese research focused on tackling gastrointestinal motility disorders. Doctors and patients had been looking for something better than metoclopramide, domperidone, and cisapride, all of which either caused troubling side effects or faced safety warnings. Japanese firm Sumitomo created Mosapride as a selective 5-HT4 receptor agonist, designed to offer relief for functional gastrointestinal issues like gastroesophageal reflux disease and chronic gastritis, but with a gentler cardiorespiratory profile than its siblings. As the years rolled by, Mosapride earned approvals across Asia and parts of the Middle East. Its safety record and ease of use built trust among gastroenterologists and general practitioners alike, stirring up interest in long-term patient cohorts and global guidelines.
This medication steps in as an oral prokinetic agent, helping the digestive tract move food efficiently by increasing the release of acetylcholine. Tablets, powders, and oral suspensions remain popular dosage forms, making it accessible for people of different ages and clinical backgrounds. Usually, a single 5 mg tablet with a meal helps most adults. Pharmacies tend to stock Mosapride under names like Gasmotin, Mosap, and ColoPrep, either as stand-alone medication or part of multi-drug digestion improvement kits. Its reputation for quick absorption and well-tolerated side effects marks it as a convenient, practical option in busy outpatient settings.
Mosapride offers a crystalline appearance, white to pale yellow, without a strong odor. Its chemical formula, C21H25ClFN3O3·C6H8O7, pairs a selective serotonin receptor agonist with citrate to improve solubility and patient absorption. The melting point hovers around 175–180°C, which keeps it stable under room temperature storage. Water solubility remains moderate — enough for dissolution but not enough to complicate shelf life. Laboratories value its stability in various pH levels, which lets them build flexible formulations. Mosapride weighs in at a molecular weight of about 567.1 g/mol (including citrate), and clinical-grade material is expected to arrive with a purity of at least 98% by HPLC, tying safety directly to reliable chemistry.
Drug labels demand clarity: chemical name, batch number, manufacturing date, expiration date, active content, and cautionary information about storage and administration. In most international standards, Mosapride Citrate is listed as 4-amino-5-chloro-N-[(1R,3S,5S)-8-chloro-5-(2-fluorobenzyl)-2,3,4,5-tetrahydro-1H-2-benzazepin-3-yl]-2-methoxybenzamide citrate. Packaging needs patient-friendly inserts, and transparency about possible allergic reactions or drug interactions. Labels also reinforce strict limits on contaminants and related substances, typically below 0.5% each, to ensure regulatory compliance in different markets.
Manufacturing Mosapride relies on controlled conditions. To synthesize the active molecule, chemists usually start from 2-methoxy-4-amino-5-chlorobenzoyl chloride, reacting with carefully protected benzazepine intermediates. Several filtration, washing, and purification steps follow each synthetic connection. After generating the free base, it’s dissolved in water and mixed with citric acid, forming the citrate salt as a precipitate. From there, the salt is filtered, dried, and milled. Production environments must minimize moisture and keep chemical residues low, as impurities affect both safety and stability. Testing at every step, from heavy metals to residual solvents, supports a transparent manufacturing process.
Scientists have tinkered with Mosapride’s structure to boost its activity or reduce side effects. Modifications at the benzamide or tetrahydrobenzazepine rings affect both selectivity and duration of gastrointestinal action. For instance, swapping the fluoro or chloro substituents can dial up or down the serotonin receptor affinity, sometimes producing analogs with improved motility but shorter half-lives. Some research teams have conjugated Mosapride with polymers or lipids, aiming for slow-release oral formulations that stretch out its effect between doses. Chemical stability studies remain a focus, as changes in pH, light exposure, or coexisting molecules can break down the core structure and change pharmacological properties. A comprehensive understanding of these changes leads to better safety and longer shelf life.
Pharmacies and research catalogs reference Mosapride under various synonyms. Besides Mosapride Citrate, chemical indexes record it as 4-amino-5-chloro-N-(1-benzylpiperidin-4-yl)-2-methoxybenzamide and Gasmotin in commercial markets. Patent literature and supply chains introduce other synonyms, but Gasmotin dominates hospital and retail language in Asia, reflecting Sumitomo’s longstanding branding campaign. Regulatory filings list the active ingredient as Mosapride Citrate Monohydrate USP or JP following regional pharmacopeia standards, giving doctors and pharmacists consistency across borders.
Every batch of Mosapride arrives with a safety certificate outlining its limits for heavy metals, microbial contamination, and residual solvents. Workers in labs or manufacturing lines wear gloves, masks, and lab coats to cut down accidental exposure and keep the product free of human-derived particulates. Storage conditions demand temperatures under 25°C and low humidity, as excessive water can cause decomposition or clumping. Operations in the plant lean on Industry 4.0 automation, tracking temperature, batch records, and worker entry points. Medical guidelines recommend against use in pregnant women without a doctor’s oversight, and anyone with a history of QT prolongation or severe heart disease. Oversight by drug regulatory agencies pushes ongoing safety monitoring, with lots regularly sampled and tested post-market.
Mosapride’s reach runs deep in gastroenterology. Doctors reach for it when treating functional dyspepsia, pediatric constipation, and slow gastric emptying after surgery. It’s a regular prescription post-endoscopy, where patients need to beat bloat or reflux. Studies support Mosapride’s positive impact on bowel evacuation times and early return to normal feeding after anesthesia. Some evidence points toward benefits for people with diabetic gastroparesis, where sluggish stomachs threaten glucose control, but care teams weigh these benefits against rare reports of cardiac changes. In veterinary medicine, a few published cases show vets using Mosapride for cats and dogs facing severe constipation. Off-label use sometimes crops up in chronic cough, hinting at unexplored serotonin pathways.
Drug discovery teams keep exploring new prokinetic agents by building off Mosapride’s skeleton. Japanese, Korean, and Indian researchers have run trials on long-acting analogs, seeing if dosing could safely drop to once a day for chronic patients. Others look at how the molecule interacts with gut microbiota, as adjusting motility might tip the balance of beneficial bacteria, reducing pain or bloating beyond mechanical movement alone. Digital health platforms include Mosapride in algorithm-based prescription tools, helping primary care clinics combine it with antacids or low-dose antidepressants to support patients with overlapping gut and mood symptoms. Small companies and university labs have engineered nanoparticles and buccal strips for delayed or targeted delivery, probing whether bypassing stomach acid could reduce pill burden and improve patient adherence over the long term.
Studies on rodents and dogs first mapped out safe limits for acute and chronic dosing. At high concentrations, Mosapride can cause tremors, labored breathing, and changes in blood pressure, mostly at doses far higher than what patients receive. Reproductive toxicity tests flag a possible risk at high, repeated doses, prompting extra caution for women planning pregnancy. In humans, the side effect spectrum looks mild—abdominal cramps, loose stools, dry mouth, and rare rashes. Cardiac researchers have measured effects on the QTc interval and rarely found clinically significant prolongation, especially compared to older prokinetics like cisapride. Still, medical guidelines recommend careful patient selection, avoiding Mosapride in those with known risk of arrhythmias or severe electrolyte disturbances. Long-term animal research supports the idea that Mosapride, at standard doses, doesn’t damage organs or trigger carcinogenesis, but continued post-approval monitoring matters in fast-changing populations.
As patients with type 2 diabetes and obesity surge in number, slow gut movement and GERD come along for the ride, keeping demand high for safe prokinetic drugs. Mosapride sits at the crossroads of evidence and evolving needs. Digital health advocates predict telemedicine clinics will increasingly favor oral prokinetics that come with simplified, well-understood side effect profiles. Drug manufacturers face pressure to innovate—improved once-a-day tablets, taste-masked powders, and quick-dissolving films look increasingly attractive for post-surgical or pediatric use. More genetic and neurohormonal studies could carve out new niches, like therapies tailored for people whose gut serotonin signaling drags down their quality of life. Ongoing investment into head-to-head trials, cost-effectiveness analysis, and remote patient monitoring will shape Mosapride’s next 20 years. Doctors, patients, and pharmacists all shape the conversation, pushing for treatments that do more good for more people, with less risk and hassle than ever before.
I know a few people who dread mealtimes, not because of the vegetables but because of the discomfort. After eating, they deal with bloating, upper stomach pain, and a sluggish gut. For some, these symptoms don’t just go away with time or ginger tea. That’s where Mosapride Citrate steps in.
This medicine gets prescribed mostly for folks with chronic indigestion, also called functional dyspepsia. It shows up in clinics across Asia, especially in Japan and China, where stubborn stomach symptoms are a common complaint. Doctors also use it for people with gastroparesis, meaning the stomach doesn’t empty properly and food just sticks around, leading to nausea or even vomiting. The discomfort isn’t small—people often struggle to eat well or sleep soundly.
Mosapride Citrate works by nudging the gut to keep moving. It boosts the action of serotonin in the GI tract, which sends a wake-up call to the nerves that control muscle contractions. That extra push moves food down the digestive pipe and out of the stomach faster. This idea isn’t unique—other “prokinetic” medicines do the same kind of trick. Metoclopramide and domperidone come up a lot in discussions. Yet, Mosapride carries less risk of certain side effects, especially those that hit the brain and nervous system. Some older drugs can cause restlessness, drowsiness, or worse, and Mosapride tends to skip most of those issues.
According to studies published in peer-reviewed medical journals, Mosapride can improve bloating, fullness, and belching, especially when traditional acid blockers fail. A big study in the World Journal of Gastroenterology reported that patients using Mosapride noticed a decent drop in discomfort scores compared to folks just taking placebos or regular acid suppressors.
For those struggling with a slow-moving gut, small victories matter. Eating out, social lunches, or even a cup of coffee can trigger stomach symptoms. Mosapride opens up those options for many people. I’ve watched friends step out of social avoidance after getting the right digestive help. It goes beyond comfort—a healthy gut allows people to focus on work, school, and relationships without looming dread of stomach pain or endless bathroom breaks.
Skepticism isn’t out of place when a new pill makes the rounds. Some worries about heart rhythm came up in the early days, which is why Mosapride Citrate's approval varies worldwide. In countries like the US, the FDA hasn’t greenlighted it, mainly out of caution about rare side effects. In Japan and other Asian countries, doctors weigh the risks and benefits for each patient. Real research shows that dangerous side effects are rare at standard doses.
No drug solves all gastric problems. Mosapride isn’t a magic fix for everyone battling digestive issues. Eating smaller meals, avoiding fatty foods, getting regular exercise—these steps matter just as much. Every patient’s tolerance and response to Mosapride looks different, so doctors decide on a case-by-case basis.
I believe real improvement comes from listening to the body, making healthy changes, and leaving space for useful medicines like Mosapride Citrate when the situation calls for it. If stomach problems keep derailing daily life, a conversation with a trusted healthcare provider about Mosapride might offer hope where other treatments have hit a wall.
Millions wrestle with digestive issues, hoping for a treatment that brings relief without trouble. For years, Mosapride Citrate has shown up on pharmacy shelves, quietly promising smoother digestion for those facing chronic gastritis, acid reflux, or slow gastric emptying. As a pharmacist who’s answered questions about this very drug, I've seen relief walk in, but I’ve also seen a few worries stick around—mostly about the side effects. Rolling up your sleeve for any new medication is never just about, “Will it work?” It’s also about, “What else comes with it?”
Doctors often point to medications like Mosapride Citrate because it encourages the stomach to move food along. Most people swallow the pill each morning and get through the day just fine. But some folks notice loose stools or mild diarrhea. A rumbling stomach, too much gas, or a bit more urgency to use the bathroom—none of these feelings are rare. Sometimes you even hear about headaches or a dry mouth. None of this surprises anyone with a few years in a pharmacy, but it still makes sense to highlight it. Most of these problems are mild and fade, and for most folks, they pale compared to having relentless heartburn.
Not all side effects announce themselves so quietly. With Mosapride Citrate, one risk—though rare—concerns the heart. The drug has a chemical cousin called cisapride that made headlines for causing dangerous heart rhythms. That led to tighter controls in the clinic. Mosapride Citrate was designed to avoid those problems by not crossing the body’s electrical signals as much, but we still see the occasional story about palpitations or chest pain. Most studies, including work out of Japan’s pharmaceutical research circles, show the risk stays low, but it isn’t zero. People with known heart disease need an honest talk with their doctor before starting.
Some might say it’s enough to trust the doctor, but anybody who’s watched their grandmother change prescriptions more than twice knows that’s not always true. It helps to bring a list of all your medications. Some drugs, such as antidepressants or antifungals, tangle up in ways that can boost side effects. Anyone with kidney or liver problems should raise it with the prescribing team. Double-checking what you swallow becomes vital here.
Kids and older folks stand at more risk for all medications, including this one. I’ve seen older patients tolerate Mosapride Citrate only after dose adjustments. Pregnant or breastfeeding mothers should talk to specialists since long-term safety data doesn’t really exist for these groups. The golden rule: Nobody benefits from playing fast and loose with new pills.
No magic pill arrives without tradeoffs. A little curiosity, and a willingness to speak up about new symptoms, pays off better than any brand promise. Pharmacists and doctors offer support, but patients catch changes at home before anyone else. With open conversations, smart monitoring, and a willingness to listen to your own body, Mosapride Citrate can remain a useful ally—or alert someone to trouble—long before risks become reality.
Mosapride Citrate comes into play for those dealing with stomach troubles, like heartburn or discomfort from slow digestion. The medicine works to speed up stomach muscle movement and clear out the stomach faster, bringing genuine relief to people who deal with that bloated, heavy feeling after a meal. Plenty of folks in the clinic where I worked would show up clutching prescriptions, barely hiding their hope that this small tablet could bring their gut back in line. But figuring out how to take it—well, daily routines make all the difference.
Your doctor’s instructions matter most. Usually, folks take Mosapride before meals. Meals slow down the medicine’s action, so popping it on an empty stomach gives it a solid chance to work. Let’s say you eat breakfast around 8:00 am—take your pill about 30 minutes ahead of time. Stick to this routine before lunch and dinner, because the rhythm helps your gut get back on track. Swallow the tablet whole with water. Crushing or chewing can mess with the release and impact how well the dose works. Missing a dose sometimes happens in the middle of a hectic day. If you remember just before your next meal, take the missed dose. Don’t double up by taking two at once; this can bring on extra side effects rather than extra benefit.
Mosapride Citrate shifts stomach function by gently activating serotonin receptors in the gut. Real results depend on regular use and eating patterns. Clinical evidence from Japan, where the drug sees frequent use, shows improved digestive flow when timing stays consistent. The medicine latches onto the gut’s own cycles, so random doses at any time of day break that cycle and blunt the benefits. In my experience, writing down pill times in a simple notebook or setting a reminder on your phone keeps things running smoothly.
Every patient wants results without setbacks. Some people run into mild side effects—dry mouth, a bit of nausea, or the jitters. In my years at the pharmacy counter, I met folks who got an upset stomach from not following the before-meal rule. A couple of sips of water help swallow the tablet and ease irritation. Occasionally, trouble shows up as abdominal pain or loose stool. If that happens or symptoms worsen, picking up the phone to talk to your healthcare provider makes more sense than waiting it out. Changes in medication or timing sort these problems out quickly.
Each person brings their own history—other pills, diseases like diabetes, or food allergies. Tinkering with your own dose or switching times after chatting with neighbors won’t bring dependable results. Drug combinations sometimes clash, so if you already take other stomach, heart, or psychiatric medications, your provider will need all those details. From what I’ve seen, honest conversations at checkups prevent a world of confusion and help doctors adjust plans before small issues grow big.
Keeping up with Mosapride Citrate takes planning. Pair pill-taking with something already part of your day, like brewing morning coffee or prepping the dinner table, and skipping or doubling up won’t happen nearly as often. Marking a calendar or pillbox keeps things clear, especially if you juggle more than one medication. From the long lines at the pharmacy to the privacy of home, clear routines lower stress and lift comfort for patients doing their best to feel normal again.
Mosapride citrate helps people with stomach problems. Doctors often prescribe it for symptoms tied to slow stomach emptying, such as heartburn, nausea, and fullness after eating only a little. By boosting gut movement, it can make life easier for those struggling with certain digestive troubles. Its effects on serotonin receptors in the gut explain why symptoms can improve.
Pregnancy brings a long list of do’s and don’ts for any medicine. Most pregnant people want clear answers from their doctors—and not every drug offers enough research to make things simple. Mosapride isn’t an exception here. Both the U.S. FDA and other international drug regulators have not given it a category for use in pregnancy, mainly because few studies track its effect on human pregnancy.
Animal research sometimes suggests that mosapride does not seem to cause birth defects. Still, animal studies rarely predict what happens in humans. Large studies in pregnant people just don’t exist for this drug. As a result, obstetricians usually stay cautious—recommending other medicines with a longer record of pregnancy safety when possible.
One real challenge: many digestive symptoms grow worse during pregnancy, which might push people to seek fast-acting medications. Choosing a drug that lacks strong safety records does not do justice to the goal of keeping risks low for the fetus. Health teams often prefer lifestyle changes and dietary tweaks first: eating smaller meals, cutting out heartburn triggers, and trying safer medications with more years of real-world data.
For parents who breastfeed, the big question circles around whether mosapride passes into milk and harms the baby. Formal research on mosapride in breastfeeding remains thin. Available evidence shows that small amounts of prokinetic drugs might get into breast milk, but there’s still too much we don’t know about its effect on infants.
The World Health Organization and other global health experts suggest that, where possible, sticking with medicine known to be safe during lactation is the best route. Doctors may choose an older alternative if a nursing infant seems sensitive or if parents report any changes in their child’s alertness or feeding while on a new medication.
There’s another angle with breastfeeding: gut problems often go hand-in-hand with stress, sleepless nights, and anxiety. Sometimes, non-drug approaches like extra fluids, gentle movement, or reassurance from a skilled lactation consultant offer real results. Sharing concerns with a pediatrician can help weigh possible drug issues against the demands of caring for a new baby.
Straight talk with an experienced doctor can help families get answers. Sharing full details on medical history, symptoms, what’s worked before, and what hasn’t gives health professionals the best shot at a safe plan. A pharmacist can check all medicines for interactions, and parents should never hesitate to report side effects or new symptoms immediately.
Pregnancy and breastfeeding are precious, challenging stretches of life. Most people remember decisions made then for years. Trust earned between families and health teams, reinforced with plain language and up-to-date evidence, lays a stronger foundation for safe, thoughtful care.
Most folks don’t wake up thinking about how their stomach medicine talks to the rest of their pillbox. Yet people with heartburn or slow digestion grab a prescription like mosapride citrate hoping to finally eat a meal without discomfort. Mosapride, a prokinetic drug, nudges food along in the digestive tract. This can transform dinner into a relief instead of an ordeal. But beneath that comfort hides a less obvious risk — the chance certain medications won’t mix well together.
Plenty of people juggling more than one health condition land behind the pharmacy counter every month, reaching for bottles with unfamiliar names. Some grab a blood pressure medicine or maybe an antifungal. That’s where real trouble can start. Take ketoconazole, a common antifungal medicine. In combination with mosapride citrate, it blocks certain liver enzymes and raises mosapride’s level in the blood. Sudden higher concentrations can bring unexpected side effects, like irregular heartbeats (QT prolongation).
Similar issues pop up with drugs called macrolide antibiotics — erythromycin and clarithromycin top this list. I've seen older adults handed an antibiotic for a chest infection, only to experience dizziness and heart thumping a few days later. These antibiotics slow down how mosapride breaks down in the body. Suddenly, a medicine that once helped now piles on a new set of problems.
One study in Japan tracked mosapride’s effect on people shielded by other frequent prescriptions. They found combinations of mosapride and certain antidepressants — SSRIs and tricyclics — sometimes led to more stomach issues or heart-related problems. Not always, but often enough to give pause. In practice, it’s rare for someone to see the story beneath a drug’s surface warnings. Many rely on busy doctors or overworked pharmacists to spot the red flags.
Another real concern comes from migraine medicines called triptans that also interact with mosapride through similar metabolic pathways in the liver. Anyone with regular migraines and gut problems faces even more confusion figuring out what’s safe.
Trust builds between a health team and the person who needs guidance. Conversations matter. Patients who share every medication and supplement — including the over-the-counter stuff — can help their doctor or pharmacist paint a complete picture. Most health systems use electronic records these days. Still, not every pharmacy shares data, and herbal supplements rarely show up unless mentioned.
Look at anyone caring for an aging parent. One brown bag review, where all medicines hit the counter for inspection, can reveal surprises. Maybe a forgotten sleeping pill. Maybe an unknown herbal tea. This honest approach, combined with pharmacists’ careful eyes and up-to-date medical records, offers real protection.
Current research stresses checking each person’s unique mix of medications. Doctors and pharmacists use drug interaction checkers that alert them to clashes between mosapride and blood thinners, antifungals, antibiotics, antipsychotics, and heart medicines. Even with technology, simple habits — asking questions, discussing symptoms, watching for new side effects — matter even more.
Mosapride citrate helps many live more comfortably. But safe use depends on honest conversations, attention to each new prescription, and the experience brought by health professionals watching out for their patients, not just filling a script. Clear communication and routine medication reviews lay the groundwork for avoiding harmful drug combinations, helping each person safely manage their health.
| Names | |
| Preferred IUPAC name | 4-amino-5-chloro-2-ethoxy-N-(1-ethylpyrrolidin-2-yl)benzamide 2-hydroxypropane-1,2,3-tricarboxylate |
| Other names |
Gasmotin Gasmotin OD Mosid Mosaprid Mosafi Mosap |
| Pronunciation | /ˈmoʊsəˌpraɪd ˈsɪtreɪt/ |
| Identifiers | |
| CAS Number | [112885-42-4] |
| Beilstein Reference | 5054074 |
| ChEBI | CHEBI:9081 |
| ChEMBL | CHEMBL19375 |
| ChemSpider | 20744459 |
| DrugBank | DB01114 |
| ECHA InfoCard | echa-infoCard-100000120860 |
| EC Number | EC Number: 613-116-9 |
| Gmelin Reference | 906753 |
| KEGG | D08206 |
| MeSH | D000068279 |
| PubChem CID | 6918493 |
| RTECS number | YXF4AH7A1P |
| UNII | QY7Y6M6G8E |
| UN number | UN3077 |
| CompTox Dashboard (EPA) | DTXSID2020207 |
| Properties | |
| Chemical formula | C21H25ClFN3O3·C6H8O7 |
| Molar mass | 609.6 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.38 g/cm³ |
| Solubility in water | Sparingly soluble in water |
| log P | 2.3 |
| Acidity (pKa) | 13.1 |
| Basicity (pKb) | 8.52 |
| Magnetic susceptibility (χ) | `-83.6 × 10⁻⁶ cm³/mol` |
| Refractive index (nD) | 1.483 |
| Dipole moment | 4.31 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 384.2 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | A03FA16 |
| Hazards | |
| Main hazards | Main hazards: Harmful if swallowed, causes eye irritation, may cause respiratory irritation. |
| GHS labelling | GHS07, GHS08 |
| Pictograms | `⚠️🚫🤰🍼🚗💊🕒` |
| Signal word | No signal word |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. |
| Flash point | 127.6°C |
| Lethal dose or concentration | LD50 (rat, oral): 4470 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Mosapride Citrate: "380 mg/kg (oral, rat) |
| NIOSH | Not Listed |
| PEL (Permissible) | 0.5 mg/m³ |
| REL (Recommended) | 5 mg |
| IDLH (Immediate danger) | Not established |
| Related compounds | |
| Related compounds |
Cisapride Prucalopride Itopride Metoclopramide Domperidone |
